prostate cancer

Open Access
⁶⁸Ga-PSMA PET/CT and Prostate Cancer Diagnosis: Which SUVmax Value?
PIETRO PEPE, LUDOVICA PEPE, MARIA TAMBURO, GIULIA MARLETTA, FRANCESCO SAVOCA, MICHELE PENNISI and FILIPPO FRAGGETTA

In Vivo May 2023, 37 (3) 1318-1322; DOI: https://doi.org/10.21873/invivo.13211
Open Access
Prostate-specific Antigen Levels Following Brachytherapy Impact Late Biochemical Recurrence in Japanese Patients With Localized Prostate Cancer
YOSHITERU UENO, TOMOHARU FUKUMORI, YOSHITO KUSUHARA, TOMOYA FUKAWA, MEGUMI TSUDA, KEI DAIZUMOTO, YUTARO SASAKI, RYOTARO TOMIDA, YASUYO YAMAMOTO, KUNIHISA YAMAGUCHI, CHISATO TONOISO, AKIKO KUBO, TAKASHI KAWANAKA, SHUNSUKE FURUTANI, HITOSHI IKUSHIMA, MASAYUKI TAKAHASHI and HIRO-OMI KANAYAMA

In Vivo March 2023, 37 (2) 738-746; DOI: https://doi.org/10.21873/invivo.13136
Open Access
Moderately Hypofractionated Helical Tomotherapy for Prostate Cancer: Ten-year Experience of a Mono-institutional Series of 415 Patients
SALVATORE COZZI, MARIA PAOLA RUGGIERI, EMANUELE ALÌ, SEBASTIANO FINOCCHI GHERSI, FEDERICA VIGO, MATTEO AUGUGLIARO, LUCIA GIACCHERINI, FEDERICO IORI, MASOUMEH NAJAFI, LILIA BARDOSCIA, ANDREA BOTTI, VALERIA TROJANI, PATRIZIA CIAMMELLA and CINZIA IOTTI

In Vivo March 2023, 37 (2) 777-785; DOI: https://doi.org/10.21873/invivo.13141
Open Access
Assessment of Prostate Volume and Prostate-specific Antigen Density With the Segmentation Method on Magnetic Resonance Imaging
YEN-TING LIN, SIU-WAN HUNG, KUN-YUAN CHIU, JYH-WEN CHAI and JIN-CHING LIN

In Vivo March 2023, 37 (2) 786-793; DOI: https://doi.org/10.21873/invivo.13142
Open Access
Distinct Expression of Surface and Genetic Biomarkers in Prostate Cancer Cell Lines
CHEN-YING SU, GWO-CHE HUANG, I-CHENG CHEN, PEI-YU CHEN, YU-JEN CHEN and HSU-WEI FANG

In Vivo January 2023, 37 (1) 242-246; DOI: https://doi.org/10.21873/invivo.13073
Open Access
Chemosensitizing Effect and Efficacy of Wilforlide A in Combination With Docetaxel in Drug-resistant Prostate Cancer
ZHIJUN WANG, STEVEN YEUNG, SHANCHAO YANG, YING HUANG and MOSES SING SUM CHOW

In Vivo September 2022, 36 (5) 2020-2031; DOI: https://doi.org/10.21873/invivo.12928
Open Access
Quantitative Analysis of Diffusion Weighted Imaging May Improve Risk Stratification of Prostatic Transition Zone Lesions
HANNES ENGEL, BENEDICT OERTHER, MARCO REISERT, ELIAS KELLNER, AUGUST SIGLE, CHRISTIAN GRATZKE, PETER BRONSERT, TOBIAS KRAUSS, FABIAN BAMBERG and MATTHIAS BENNDORF

In Vivo September 2022, 36 (5) 2323-2331; DOI: https://doi.org/10.21873/invivo.12963
Open Access
Non-invasively Imageable Tibia-tumor-fragment Implantation Experimental-bone-metastasis Mouse Model of GFP-expressing Prostate Cancer
YUSUKE AOKI, NORIYUKI MASAKI, YASUNORI TOME, YUTARO KUBOTA, YASUYO AOKI, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN

In Vivo July 2022, 36 (4) 1647-1650; DOI: https://doi.org/10.21873/invivo.12876
Open Access
Cranial Radiotherapy for Prostate Cancer Patients With Brain Metastases Inaccessible to Stereotactic Radiotherapy
CHRISTINA SCHRÖDER, PAUL WINDISCH, JAMIE LÜTSCHER, DANIEL R. ZWAHLEN and ROBERT FÖRSTER

In Vivo July 2022, 36 (4) 1841-1846; DOI: https://doi.org/10.21873/invivo.12901
Open Access
Acute and Late Rectal Toxicity Following Hypofractionated Radiotherapy in Patients With Prostate Cancer: Results of a Prospective Study
GEORGIOS KOUNADIS, NIKOLAOS SYRIGOS, ANDROMACHI KOUGIOUMTZOPOULOU, GEORGIOS BAMIAS, ILIAS KOTTEAS, GEORGIOS PAPATHEODORIDIS and DIMITRA GRAPSA

In Vivo July 2022, 36 (4) 1875-1880; DOI: https://doi.org/10.21873/invivo.12906

Main menu

User menu

Search

prostate cancer

Pages